Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC

Clinical trial NCT04846478 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04846478
Sponsor: Dana-Farber Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2021-06-28
Primary completion: 2025-09-25
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.